Search filters

List of works by Stephen M Ansell

A Phase II study of (153)Sm-EDTMP and high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myeloma

scientific article published on June 2010

A phase 1b study of dual PD-1 and CTLA-4 or KIR blockade in patients with relapsed/refractory lymphoid malignancies

scientific article published on 29 June 2020

A phase 2 study of lenalidomide, rituximab, cyclophosphamide, and dexamethasone (LR-CD) for untreated low-grade non-Hodgkin lymphoma requiring therapy

scientific article published on 23 February 2017

A phase I/II trial of reduced intensity allogeneic hematopoietic cell transplant for hematologic malignancies using cladribine, thiotepa and rabbit antithymocyte globulin

scientific article published on 31 December 2012

Aberrant Extrafollicular B Cells, Immune Dysfunction, Myeloid Inflammation, and MyD88-Mutant Progenitors Precede Waldenstrom Macroglobulinemia

scientific article published on 01 September 2021

Absolute values of immunoglobulin free light chains are prognostic in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation

scientific article published on 5 January 2006

Activating the Antitumor Immune Response in Non-Hodgkin Lymphoma Using Immune Checkpoint Inhibitors

scientific article published on 18 November 2020

Autologous stem cell transplant for immunoglobulin light chain amyloidosis: a status report

scientific article published on 20 October 2010

Autologous stem cell transplant in 716 patients with multiple myeloma: low treatment-related mortality, feasibility of outpatient transplant, and effect of a multidisciplinary quality initiative

scientific article

Bendamustine and rituximab (BR) versus dexamethasone, rituximab, and cyclophosphamide (DRC) in patients with Waldenström macroglobulinemia

scientific article published on 03 April 2018

Brentuximab vedotin with chemotherapy for stage III or IV classical Hodgkin lymphoma (ECHELON-1): 5-year update of an international, open-label, randomised, phase 3 trial

Cost-effectiveness analysis of a risk-adapted algorithm of plerixafor use for autologous peripheral blood stem cell mobilization

scientific article published on 23 August 2012

Detection of extranodal and spleen involvement by FDG-PET imaging predicts adverse survival in untreated follicular lymphoma

scientific article published on 16 May 2019

Dexamethasone, rituximab and cyclophosphamide for relapsed and/or refractory and treatment-naïve patients with Waldenstrom macroglobulinemia

scientific article published on 08 August 2017

Diagnosis and Management of Waldenström Macroglobulinemia: Mayo Stratification of Macroglobulinemia and Risk-Adapted Therapy (mSMART) Guidelines 2016.

scientific article published on 05 January 2017

Diagnosis and management of Waldenström macroglobulinemia: Mayo stratification of macroglobulinemia and risk-adapted therapy (mSMART) guidelines

scientific article

Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation for patients with primary systemic amyloidosis

scientific article published on 01 February 2005

First report of MYD88 L265P somatic mutation in IgM-associated light-chain amyloidosis

scientific article published on 31 March 2016

Five-year follow-up of brentuximab vedotin combined with ABVD or AVD for advanced-stage classical Hodgkin lymphoma

scientific article published on 21 July 2017

Hodgkin Lymphoma: 2020 update on diagnosis, risk-stratification, and management

scientific article published on 08 May 2020

Hodgkin lymphoma: 2018 update on diagnosis, risk-stratification, and management.

scientific article published in May 2018

Ibrutinib for the treatment of Bing-Neel syndrome: a multicenter study

scientific article published on 06 December 2018

Ibrutinib monotherapy outside of clinical trial setting in Waldenström macroglobulinaemia: practice patterns, toxicities and outcomes

scientific article published on 29 August 2019

IgM AL amyloidosis: delineating disease biology and outcomes with clinical, genomic and bone marrow morphological features

scientific article published on 28 November 2019

Impact of MYD88L265P mutation status on histological transformation of Waldenström Macroglobulinemia

scientific article published on 31 December 2019

Incidence of supraventricular arrhythmias during autologous peripheral blood stem cell transplantation

scientific article published on 06 June 2013

Kidney Involvement of Patients with Waldenström Macroglobulinemia and Other IgM-Producing B Cell Lymphoproliferative Disorders

scientific article published on 30 May 2018

Long-term Outcomes of Sequential Hematopoietic Stem Cell Transplantation and Kidney Transplantation: Single-center Experience

scientific article published on 07 October 2020

Long-term outcome of allogeneic stem cell transplantation in chronic lymphocytic leukemia: analysis after a minimum follow-up of 5 years

scientific article

Long-term outcomes after autologous stem cell transplantation for patients with POEMS syndrome (osteosclerotic myeloma): a single-center experience

scientific article

MYD88 mutation status does not impact overall survival in Waldenström macroglobulinemia.

scientific article published on 28 October 2017

Management of newly diagnosed symptomatic multiple myeloma: updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus guidelines 2013.

scientific article published on April 2013

Partial response or better at six months is prognostic of superior progression-free survival in Waldenström macroglobulinaemia patients treated with ibrutinib

scientific article published on 18 November 2020

Pembrolizumab: living up to expectations

scientific article published on 01 October 2019

Peripheral blood stem cell transplant for POEMS syndrome is associated with high rates of engraftment syndrome

scientific article published on 23 January 2008

Phase II trial of the oral mammalian target of rapamycin inhibitor everolimus in relapsed or refractory Waldenstrom macroglobulinemia

scientific article

Phenotype, Function, and Clinical Significance of CD26+ and CD161+Tregs in Splenic Marginal Zone Lymphoma

scientific article published in 2022

Posttransplantation thrombotic thrombocytopenic purpura: a single-center experience and a contemporary review

scientific article

Predictors of short-term survival in Waldenström Macroglobulinemia

scientific article published on 14 July 2020

Predictors of symptomatic hyperviscosity in Waldenström macroglobulinemia

scientific article published on 02 October 2018

Prevalence, clinical characteristics and prognosis of EBV-positive follicular lymphoma

scientific article published on 05 December 2018

Primary systemic amyloidosis in patients with Waldenström macroglobulinemia

scientific article published on 12 October 2018

Prognostication of survival using cardiac troponins and N-terminal pro-brain natriuretic peptide in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation

scientific article published on 25 March 2004

Response assessment in Waldenström macroglobulinaemia: update from the VIth International Workshop

scientific article

Stem cell transplantation for the management of primary systemic amyloidosis

scientific article

Superior survival in primary systemic amyloidosis patients undergoing peripheral blood stem cell transplantation: a case-control study

scientific article published on 22 January 2004

The definition of IgM multiple myeloma

scholarly article by Steven R. Schuster et al published 14 July 2011 in American Journal of Hematology

The effect of absolute lymphocyte count recovery kinetics on survival after autologous stem cell transplantation for non-Hodgkin's lymphoma

scientific article published on September 2005

Treatment facility volume and patient outcomes in Waldenstrom macroglobulinemia

scientific article published on 15 October 2020

Treatment recommendations from the Eighth International Workshop on Waldenström's Macroglobulinemia

scientific article published on 18 July 2016

Two types of amyloidosis presenting in a single patient: a case series

scientific article published on 05 March 2019

Paulina is supported by:

About Paulina

Help